OM DENNE EPISODE
In this new episode of the pharmaphorum podcast, host Nicole Raleigh speaks with James Burt, CEO of Pharmanovia, about the value-added medicines space.
Engelsk
USA
UDSKRIFT 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
SØG BLANDT TIDLIGERE EPISODER
Søg efter gamle afsnit af pharmaphorum Podcast.
ANDRE EPISODE I DENNE PODCAST
*This episode of the pharmaphorum podcast is brought to you in association with Klick Health*
When it comes to digital innovation and AI, consideration of using and implementing such responsibly and ethically ever more becomes forefront. But how can pharma lead the way in ethical AI and trust-driv…
Public demand for prevention is surging, with 33.6 million people now using the NHS App, yet, NHS leaders say the digital infrastructure required to deliver prevention at scale isn’t in place.
In a new episode of the podcast, pharmaphorum spoke with James Davis, a healthcare expert at PA Consultin…
Earlier this year, the FDA released draft guidance endorsing Bayesian methods and simulation-based evidence in clinical trials in a significant shift in how regulators think about predictive medicine.
In a new pharmaphorum podcast, Dr Irina Babina, CEO of oncology R&D platform Concr, discusse…
*This episode of the pharmaphorum podcast is brought to you in association with Klick Health*
Europe continues to offer major life sciences advantages: deep scientific talent, strong clinical expertise, mature research infrastructure, and significant manufacturing capability. Indeed, biotech compa…
For a variety of reasons, early stage clinical trials have been moving out of the United States more and more over the past few years, as companies pursue savings and lighter regulatory burden in places like China and Australia. The industry has long urged the US government to take some action to m…
Ansvarsfraskrivelse: Podcasten og kunstværket, der er indlejret på denne side, er fra pharmaphorum, som tilhører dens ejer og ikke er tilknyttet eller godkendt af Listen Notes, Inc.
REDIG
Tak fordi du hjælper med at holde podcast-databasen opdateret.
